Health Dictionary Find a Doctor

Renal oncocytoma

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Synonyms and keywords: Oncocytoma of kidney, proximal tubular adenoma, oncocytic adenoma, oncocytic renal adenoma

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

Renal oncocytoma is a relatively rare and benign tumor. The incidence of is approximately 3% to 7% of solid renal resected tumors and it is more common in male patients. The majority of patients with renal oncocytoma are asymptomatic. Symptoms of renal oncocytoma include hematuria, flank pain, abdominal or flank mass and weight loss. Physical examination of patients with renal oncocytoma is usually normal. An abdominal or flank mass may be palpayed during physical examination. Surgery is the mainstay of treatment for renal oncocytoma. Although the nature of renal oncocytoma is benign and the prognosis is excellent, since the definite diagnosis can not be obtained before operation, surgical resection is a choice of treatment.

Historical perspective

Renal oncocytoma was first discovered by Zippel, in 1942 and Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features” in 1976.

Classification

There is no established system for the classification of renal oncocytoma.

Pathophysiology

The exact pathogenesis of renal oncocytoma is not completely understood. Although some mechanisms are suggested in the pathogenesis of this disease that include, lossing of chromosome 1 and dysfunction of mitochondrial enzymes which is caused by alterations in the mitochondrial DNA. DNA diploidy is seen in 96% of patients with renal oncocytomas. The development of renal oncocytoma is the result of multiple genetic mutations such as deletion of chromosome 1, deletion of the sex chromosome, translocation of chromosome 11q13, sporadic or no chromosomal alteration. Renal oncocytoma can be associated with familial renal oncocytoma or Birt-Hogg-Dube syndrome. On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma. On microscopichistopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilicgranular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.

Causes

There are no established causes for renal oncocytoma.

Differential Diagnosis

Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass.

Epidemiology and Demographics

The incidence of renal oncocytoma is approximately 3% to 7% of solid renal resected tumors. Patients of all age groups may develop renal oncocytoma. The age of patients can be differ from 10 to 94 years. The incidence of renal oncocytoma increases with age; the median age at the time of surgery is 62 to 68 years. Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.

Risk Fctors

Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).

Screening

There is insufficient evidence to recommend routine screening for renal oncocytoma.

Natural History, Complications and Prognosis

The median age at the time of surgery is 62 to 68 years. In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen. Prognosis is generally excellent, There are only two cases of metastatic renal oncocytoma were reported. Since the definite diagnosis is maintain just after surgery, most of patients are undergone operation.

Diagnosis

History and Symptoms

The majority of patients with renal oncocytoma are asymptomatic. Symptoms are seen in almost only 17% to 21% of patients with renal oncocytoma. Symptoms of renal oncocytoma include hematuria, flank pain, abdominal or flank mass and weight loss.

Physical Examination

Physical examination of patients with renal oncocytoma is usually normal. An abdominal or flank mass may be palpayed during physical examination.

Laboratory Findings

Some patients with renal oncocytoma may have hematuria, in their urine analysis.

X Ray

X-ray is rarely done for the diagnosis of renal oncocytoma.

CT Scan

Abdominal CT scan may be helpful in the diagnosis of renal oncocytoma. Findings on CT scan suggestive ofrenal oncocytoma include solid renal lesion, centralscar (stellate scar), hypervascularity, hypodenseity ( most of the time), and homogenous enhancements.

MRI

Renal MRI may be helpful in the diagnosis of renal oncocytoma. Findings on MRI suggestive of renal oncocytoma include central scar, satellite pattern, pseudo-capsule, hypointensity in T1 and hyperintensity in T2 weighted images. Although, none of these characteristics can differentiate between renal oncocytoma and RCC.

Ultrasound

Renal ultrasound in renal oncocytoma patients may show: solid mass ( help to distinguish solid from cystic mass), central scarring, calcification, central necrosis which none of them characteristics for indicating a specific renal lesion.

Other Imaging Findings

Renal angiography may be helpful in the diagnosis of renal oncocytoma. The “spoke-wheeled” appearance, lucent rim sign, homogeneous capillary flush in the nephrogram phase, lack of wild neoplastic vessels,and both hypovascular or hypervascular may seen on angiography of patients with renal oncocytoma. Although, none of them are specific for renal oncocytoma and they also may seen in RCCs.

Other Diagnostic Studies

Renal mass biopsy may be helpful in the diagnosis of renal oncocytoma. However, distinguishing between oncocytoma and RCC by biopsy is difficult. Since this method only reserved for patients who are at high risk for an operation like very elderly or extremely sick patients. Some complications may happen during renal mass biopsy which are perirenal hemorrhage, pneumothorax ( during biopsy of upper pole tumors) and tumor seeding.

Treatment

Medical Therapy

The mainstay of therapy for renal oncocytoma is surgery.

Surgery

Surgery is the mainstay of treatment for renal oncocytoma. Although the nature of renal oncocytoma is benign and the prognosis is excellent, since the definite diagnosis can not be obtained before operation, surgical resection is a choice of treatment. Best option for surgery differs based on the mass characteristics, partial nephrectomy is done in polar lesions smaller than 4 cm in a normal contralateral kidney while, large solid renal masses which destroy most part of renal tissue or patients who have not candidate for nephron-sparing surgery are reserved for total nephrectomy.

Primary Prevention

There are no established measures for the primary prevention of renal oncocytoma.

Secondary Prevention

There are no established measures for the secondary prevention of renal oncocytoma.

References

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Renal oncocytoma was first discovered by Zippel, in 1942 and Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features” in 1976.

Historical Perspective

Discovery

  • Renal oncocytoma was first discovered by Zippel, in 1942.[1]
  • In 1976, Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features”.[2]

References

  1. Stephen M. Schatz & Michael M. Lieber (2003). “Update on oncocytoma”. Current urology reports. 4 (1): 30–35. PMID 12537936. Unknown parameter |month= ignored (help)
  2. M. J. Klein & Q. J. Valensi (1976). “Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm”. Cancer. 38 (2): 906–914. PMID 975006. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

There is no established system for the classification of renal oncocytoma.

Classification

There is no established system for the classification of renal oncocytoma.

References

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

The exact pathogenesis of renal oncocytoma is not completely understood. Although some mechanisms are suggested in the pathogenesis of this disease that include, lossing of chromosome 1 and dysfunction of mitochondrial enzymes which is caused by alterations in the mitochondrial DNA. DNA diploidy is seen in 96% of patients with renal oncocytomas. The development of renal oncocytoma is the result of multiple genetic mutations such as deletion of chromosome 1, deletion of the sex chromosome, translocation of chromosome 11q13, sporadic or no chromosomal alteration. Renal oncocytoma can be associated with familial renal oncocytoma or Birt-Hogg-Dube syndrome. On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma. On microscopic histopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilic granular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.

Pathophysiology

Pathogenesis

Genetics

DNA diploidy is seen in 96% of patients with renal oncocytomas.[5][6][7]

The development of renal oncocytoma is the result of multiple genetic mutations such as:[8][9][10][1][2][11]

Associated Conditions

Conditions associated with renal oncocytoma include:[12][13]

Note: Birt-Hogg-Dube syndrome is an autosomal dominant syndrome which is presented with different types of dermatologic diseases and renal epithelial tumors such as renal oncocytoma and RCCs.

Gross Pathology

On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma.[14][15][16][17][18][19]

https://radiopaedia.org/cases/renal-oncocytoma-gross-pathology-2?lang=us
https://radiopaedia.org/cases/renal-oncocytoma-pathology-2?lang=us

Microscopic Pathology

On microscopic histopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilic granular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.[20][21][22][23][24]

https://openi.nlm.nih.gov/detailedresult?img=PMC3557568_rt-2012-4-e54-g003&query=renal%20oncocytoma&it=xg&req=4&npos=61
https://openi.nlm.nih.gov/detailedresult?img=PMC3306738_1471-2369-13-9-1&query=renal%20oncocytoma&it=xg&req=4&npos=41

References

  1. 1.0 1.1 Thrash-Bingham, Catherine A.; Salazar, Hernando; Greenberg, Richard E.; Tartof, Kenneth D. (1996). “Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas”. Genes, Chromosomes and Cancer. 16 (1): 64–67. doi:10.1002/(SICI)1098-2264(199605)16:1<64::AID-GCC9>3.0.CO;2-1. ISSN 1045-2257.
  2. 2.0 2.1 Dijkhuizen, T.; van den Berg, E.; Störkel, S.; de Vries, B.; van der Veen, A.Y.; Wilbrink, M.; Geurts van Kessel, A.; de Jong, B. (1997). “Renal oncocytoma with t(5;12;11), der(1)t(1;8) and add(19): “true” oncocytoma or chromophobe adenoma?”. International Journal of Cancer. 73 (4): 521–524. doi:10.1002/(SICI)1097-0215(19971114)73:4<521::AID-IJC11>3.0.CO;2-C. ISSN 0020-7136.
  3. Neuhaus, Christine; Dijkhuizen, T.; van den Berg, E.; Störkel, S.; Stöckle, M.; Mensch, B.; Huber, C.; Decker, H.-J. (1997). “Involvement of the chromosomal region 11q13 in renal oncocytoma: Case report and literature review”. Cancer Genetics and Cytogenetics. 94 (2): 95–98. doi:10.1016/S0165-4608(96)00205-1. ISSN 0165-4608.
  4. C. Welter, G. Kovacs, G. Seitz & N. Blin (1989). “Alteration of mitochondrial DNA in human oncocytomas”. Genes, chromosomes & cancer. 1 (1): 79–82. PMID 2487148. Unknown parameter |month= ignored (help)
  5. M. R. Licht, A. C. Novick, R. R. Tubbs, E. A. Klein, H. S. Levin & S. B. Streem (1993). “Renal oncocytoma: clinical and biological correlates”. The Journal of urology. 150 (5 Pt 1): 1380–1383. PMID 8411404. Unknown parameter |month= ignored (help)
  6. J. Hartwick, R. Warren; El-Naggar, Adel K.; Ro, Jae Y.; Srigley, John R.; Mclemore, Donia D.; Jones, Edward C.; Grignon, David J.; Thomas, M. Jane; Ayala, Alberto G. (1992). “Renal Oncocytoma and Granular Renal Cell Carcinoma: A Comparative Clinicopathologic and DNA Flow Cytometric Study”. American Journal of Clinical Pathology. 98 (6): 587–593. doi:10.1093/ajcp/98.6.587. ISSN 1943-7722.
  7. L. Fuzesi, B. Gunawan, S. Braun, F. Bergmann, A. Brauers, P. Effert & C. Mittermayer (1998). “Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly”. Cancer genetics and cytogenetics. 107 (1): 1–6. PMID 9809026. Unknown parameter |month= ignored (help)
  8. L. Fuzesi, B. Gunawan, S. Braun, F. Bergmann, A. Brauers, P. Effert & C. Mittermayer (1998). “Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly”. Cancer genetics and cytogenetics. 107 (1): 1–6. PMID 9809026. Unknown parameter |month= ignored (help)
  9. Presti, Joseph C.; Moch, Holger; Reuter, Victor E.; Huynh, Danh; Waldman, Frederic M. (1996). “Comparative genomic hybridization for genetic analysis of renal oncocytomas”. Genes, Chromosomes and Cancer. 17 (4): 199–204. doi:10.1002/(SICI)1098-2264(199612)17:4<199::AID-GCC1>3.0.CO;2-Z. ISSN 1045-2257.
  10. van den Berg, E.; Dijkhuizen, T.; Störkel, S.; Brutel de la Rivière, G.; Dam, A.; Mensink, H.J.A.; Oosterhuis, J.W.; de Jong, B. (1995). “Chromosomal changes in renal oncocytomas Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas”. Cancer Genetics and Cytogenetics. 79 (2): 164–168. doi:10.1016/0165-4608(94)00142-X. ISSN 0165-4608.
  11. R. J. Sinke, T. Dijkhuizen, B. Janssen, D. Olde Weghuis, G. Merkx, E. van den Berg, E. Schuuring, A. M. Meloni, B. de Jong & A. Geurts van Kessel (1997). “Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint”. Cancer genetics and cytogenetics. 96 (2): 95–101. PMID 9216713. Unknown parameter |month= ignored (help)
  12. G. Weirich, G. Glenn, K. Junker, M. Merino, S. Storkel, I. Lubensky, P. Choyke, S. Pack, M. Amin, M. M. Walther, W. M. Linehan & B. Zbar (1998). “Familial renal oncocytoma: clinicopathological study of 5 families”. The Journal of urology. 160 (2): 335–340. PMID 9679872. Unknown parameter |month= ignored (help)
  13. J. R. Toro, G. Glenn, P. Duray, T. Darling, G. Weirich, B. Zbar, M. Linehan & M. L. Turner (1999). “Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia”. Archives of dermatology. 135 (10): 1195–1202. PMID 10522666. Unknown parameter |month= ignored (help)
  14. Moch, Holger; Cubilla, Antonio L.; Humphrey, Peter A.; Reuter, Victor E.; Ulbright, Thomas M. (2016). “The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours”. European Urology. 70 (1): 93–105. doi:10.1016/j.eururo.2016.02.029. ISSN 0302-2838.
  15. Amin, Mahul B.; Crotty, Thomas B.; Tickoo, Satish K.; Farrow, George M. (1997). “Renal Oncocytoma: A Reappraisal of Morphologic Features with Clinicopathologic Findings in 80 Cases”. The American Journal of Surgical Pathology. 21 (1): 1–12. doi:10.1097/00000478-199701000-00001. ISSN 0147-5185.
  16. Perez-Ordonez, Bayardo; Hamed, Ghiath; Campbell, Steve; Erlandson, Robert; Russo, Paul; Gaudin, Paul; Reuter, Victor (1997). American Journal of Surgical Pathology. 21 (8): 871–883. doi:10.1097/00000478-199708000-00001. ISSN 0147-5185. Missing or empty |title= (help)
  17. Trpkov, Kiril; Yilmaz, Asli; Uzer, Dina; Dishongh, Kristin M; Quick, Charles M; Bismar, Tarek A; Gokden, Neriman (2010). “Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features”. Histopathology. 57 (6): 893–906. doi:10.1111/j.1365-2559.2010.03726.x. ISSN 0309-0167.
  18. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  19. F. Bertoni, C. Ferri, P. Bacchini, G. Corrado, A. Benati, D. Mannini & F. Corrado (1989). “Oncocytoma and low-grade oncocytic carcinoma of the kidney”. European urology. 16 (2): 101–109. PMID 2714326.
  20. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  21. Barnes, C. Allan; Beckman, Edwin N. (1983). “Renal Oncocytoma and Its Congeners”. American Journal of Clinical Pathology. 79 (3): 312–318. doi:10.1093/ajcp/79.3.312. ISSN 1943-7722.
  22. H. Choi, U. A. Almagro, J. T. McManus, D. H. Norback & S. C. Jacobs (1983). “Renal oncocytoma. A clinicopathologic study”. Cancer. 51 (10): 1887–1896. PMID 6831354. Unknown parameter |month= ignored (help)
  23. M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter |month= ignored (help)
  24. J. N. Eble & M. T. Hull (1984). “Morphologic features of renal oncocytoma: a light and electron microscopic study”. Human pathology. 15 (11): 1054–1061. PMID 6490001. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

There are no established causes for renal oncocytoma.

Causes

There are no established causes for renal oncocytoma.

References

Template:WH Template:WS

Differentiating Renal oncocytoma from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]Sargun Singh Walia M.B.B.S.[4]

Overview

Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass.

Differentiating renal oncocytoma from other Diseases

Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as Wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass..


 
 
 
 
 
 
 
 
 
 
 
Genetic differentiation between renal oncocytoma and RCC subtypes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common chromosomal alteration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Deletion of chromosome 1 and X/Y

2. A balanced translocation involving 11q13

3. Sporadic or no chromosomal alterations
 
 
 
 
Loss of heterozygosity chromosome 1, 2, 6, 10, 13,17, and 21
 
 
 
 
Additional copies of chromosomes 7, 12, and 17
 
 
 
 
Loss of heterozygosity chromosome 3p
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oncocytoma
 
 
 
 
chromophobe RCC
 
 
 
 
Papillary RCC
 
 
 
 
Nonpapillary RCC

Differentiating renal oncocytoma from other diseases on the basis of abdominal pain, hematuria, and headache

Renal oncocytomas should be differentiated from other diseases that cause abdominal pain, hematuria and headache. The differentials include the following:[1][2][3][4][5][6][7][8][9]

S.No. Disease Symptoms Signs Diagnosis Comments
Abdominal Pain Hematuria Headache Abdominal mass Abdominal tenderness Ultrasonography CT scan Histology
1. Renal oncocytoma +/- + /- +/- +/- Renal ultrasound in renal oncocytoma patients may show: Abdominal CT scan may be helpful in the diagnosis of renal oncocytoma. Findings on CT scan suggestive of renal oncocytoma include:
  • Wilms tumor has a triphasic appearance.
  • It is comprised of 3 types of cells:
  • All the 3 types are not required for the diagnosis of Wilms tumor.
  • Primitive tubules and glomeruli are often seen comprised of neoplastic cells.
  • Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.
2. Wilms tumor + + + +
  • Wilms tumor has a triphasic appearance.
  • It is comprised of 3 types of cells:
  • All the 3 types are not required for the diagnosis of Wilms tumor.
  • Primitive tubules and glomeruli are often seen comprised of neoplastic cells.
  • Beckwith and Palmer reported in NWTS the different histopathologic types of Wilms tumor to categorize them based on prognosis.[10]
3. Renal cell carcinoma + + +/- +
  • Ultrasound (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound.
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. The histological pattern of renal cell carcinoma depends whether it is papillary, chromophobe or collecting duct renal cell carcinoma.
4. Rhabdoid kidney disease + + +
  • CT scan may be diagnostic of malignant rhabdoid tumor. Findings on CT scan suggestive of malignant rhabdoid tumor include a large, heterogenous, centrally located mass, which is lobulated with individual lobules separated by intervening areas of decreased attenuation, relating to either previous hemorrhage or necrosis. Enhancement is similarly heterogeneous. Calcification is relatively common, observed in 20-50% of cases and is typically linear and tends to outline tumor lobules.
  • Malignant rhabdoid tumor is characterized by the round blue tumor cells of high cellularity composed of atypical cells with eccentric nuclei, small nucleoli, and abundant amounts of eosinophilic cytoplasm with frequent mitotic figures.
5. Polycystic kidney disease + + + (from hypertension) +

Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include:

  • At least three unilateral or bilateral cysts in patients 15 – 39 years old
  • Atleast two cysts in each kidney in patients 40 – 59 years old
  • Atleast four cysts in each kidney in patients 60 years of age or older

Renal CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include:

  • Numerous renal cysts of varying size and shape with little intervening parenchyma with water attenuation and very thin wall.
  • Reduction in sinus fat due to expansion of the cortex
  • Occasional complex cysts with hyperdense appearance, with possible septations or calcifications
  • Multiple homogeneous and hypoattenuating cystic lesions in the liver in patients with liver involvement
  • On microscopic histopathological analysis, interstitial fibrosis, tubular atrophy, thickening and lamellation of tubular basement membranes, microcysts and negative immunofluorescence for complement and immunoglobulin are characteristic findings of ADPKD.
6. Pheochromocytoma + (as a part of the hypertension paroxysm)
  • CT is the preferred imaging modality for the diagnosis of pheochromocytoma.
The following findings may be observed on CT scan:
  • On microscopic pathology, Pheochromocytoma typically demonstrates a nesting (Zellballen) pattern on microscopy. This pattern is composed of well-defined clusters of tumor cells containing eosinophilic cytoplasm separated by fibrovascular stroma.
7. Burkitt lymphoma +/- (in non-endemic or sporadic form of the disease)
  • Chest, abdomen, and pelvis CT scan may be helpful in the diagnosis of Burkitt’s lymphoma but it is not done routinely.
  • On microscopic histopathological analysis, characteristic findings of Burkitt’s lymphoma include:
  • Medium-sized (~1.5-2x the size of a RBC) with uniform size (“monotonous”) — key feature (i.e. tumor nuclei size similar to that of histiocytes or endothelial cells)
  • Round nucleus
  • Small nucleoli
  • Relatively abundant cytoplasm (basophilic)
  • Brisk mitotic rate and apoptotic activity
  • Cellular outline usually appears squared off
  • “Starry-sky pattern”:
  • The stars in the pattern are tingible-body macrophages (macrophages containing apoptotic tumor cells.
  • The tumour cells are the sky
8. Intussusception + +/- +
  • Ultrasound is the gold standard imaging modality used to diagnose intussusception
    • Target or doughnut sign
      • Edematous intussuscipien forms an external ring around the centrally located intussusceptum
      • Target sign is usually seen in right lower quadrant
    • Layers of intussusception forms pseudo-kidney appearance on the transverse view
  • CT scan may be helpful in the diagnosis of intussusception. CT scan maybe used when other image modalities like x-ray and ultrasound have not given positive results but suspicion of intussusception is high.
  • Intussusception occurs if there is an imbalance between the longitudinal and radial smooth muscle forces of intestine that maintain its normal structure. This imbalance leads to a segment of intestine to invaginate into another segment and cause entero-enteral intussusception. Etiology of intussusception is either idiopathic or pathologic (lead point). 
9. Hydronephrosis + +/- + (CVA tenderness in case of pyelonephritis)
  • In the case of renal colic (one sided loin pain usually accompanied by a trace of blood in the urine) the initial investigation is usually an intravenous urogram. This has the advantage of showing whether there is any obstruction of flow of urine causing hydronephrosis as well as demonstrating the function of the other kidney. Many stones are not visible on plain x ray or IVU but 99% of stones are visible on CT and therefore CT is becoming a common choice of initial investigation.
  • The kidney undergoes extensive dilation with atrophy and thinning of the renal cortex.
10. Dysplastic kidney N/A N/A N/A N/A N/A

MCDK is usually diagnosed by ultrasound examination before birth.

  • Mass of non-communicating cysts of variable size.
  • Unlike severe hydronephrosis, in which the largest cystic structure (the renal pelvis) lies in a central location and is surrounded by dilated calices, in multicystic dysplastic kidney the cyst distribution shows no recognizable pattern.
  • Dysplastic, echogenic parenchyma may be visible between the cysts, but no normal renal parenchyma is seen.
  • MCKD can be discovered accidentally on CT scan.
  • CT scan shows myltiple cysts with absence of renal parenchyma.
  • MCKD is the result of abnormal differentiation of the renal parenchyma.
11. Pediatric Neuroblastoma + +/- +/-
  • On ultrasound, neuroblastoma is characterized by a heterogeneous echogenicity due to the vascular, necrotic, and calcified content of the mass.
  • CT scan is the investigation of choice for the diagnosis of neuroblastoma.
  • On CT scan, neuroblastoma is characterized by:
  • On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
  • Other findings of neuroblastoma on light microscopy may include:
  • Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center)
  • Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
12. Pediatric Rhabdomyosarcoma + +/- +/- +/- On CT scan, rhabdomyosarocma is characterized by:
  • Soft tissue density
  • Some enhancement with contrast
  • Adjacent bony destruction (over 20% of cases)
13. Mesoblastic nephroma + + +
  • Ultrasound may be helpful in the diagnosis of mesoblastic nephroma.
  • Mesoblastic nephroma may presents as a well-defined mass with low-level homogeneous echoes.
  • The presence of concentric echogenic and hypoechoic rings can be a helpful diagnostic feature of mesoblastic nephroma.
  • CT scan may be helpful in the diagnosis of mesoblastic nephroma.
  • Findings on CT scan suggestive of mesoblastic nephroma include:
  • Solid hypoattenuating renal lesion
  • Variable contrast enhancement
  • No calcification

Template:WH Template:WS

References

  1. D. S. Hartman & R. C. Sanders (1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 1 (3): 117–122. PMID 6152936. Unknown parameter |month= ignored (help)
  2. J. F. De Campo (1986). “Ultrasound of Wilms’ tumor”. Pediatric radiology. 16 (1): 21–24. PMID 3003660.
  3. Sara E. Wobker & Sean R. Williamson (2017). “Modern Pathologic Diagnosis of Renal Oncocytoma”. Journal of kidney cancer and VHL. 4 (4): 1–12. doi:10.15586/jkcvhl.2017.96. PMID 29090117.
  4. Bita Geramizadeh, Mahmoud Ravanshad & Marjan Rahsaz (2008). “Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma”. Indian journal of pathology & microbiology. 51 (2): 167–171. PMID 18603673. Unknown parameter |month= ignored (help)
  5. Oleksandr N. Kryvenko, Merce Jorda, Pedram Argani & Jonathan I. Epstein (2014). “Diagnostic approach to eosinophilic renal neoplasms”. Archives of pathology & laboratory medicine. 138 (11): 1531–1541. doi:10.5858/arpa.2013-0653-RA. PMID 25357116. Unknown parameter |month= ignored (help)
  6. A. M. Amar, G. Tomlinson, D. M. Green, N. E. Breslow & P. A. de Alarcon (2001). “Clinical presentation of rhabdoid tumors of the kidney”. Journal of pediatric hematology/oncology. 23 (2): 105–108. PMID 11216700. Unknown parameter |month= ignored (help)
  7. T. I. Han, M. J. Kim, H. K. Yoon, J. Y. Chung & K. Choeh (2001). “Rhabdoid tumour of the kidney: imaging findings”. Pediatric radiology. 31 (4): 233–237. doi:10.1007/s002470000417. PMID 11321739. Unknown parameter |month= ignored (help)
  8. S. L. Gooskens, M. E. Houwing, G. M. Vujanic, J. S. Dome, T. Diertens, A. Coulomb-l’Hermine, J. Godzinski, K. Pritchard-Jones, N. Graf & M. M. van den Heuvel-Eibrink (2017). “Congenital mesoblastic nephroma 50 years after its recognition: A narrative review”. Pediatric blood & cancer. 64 (7). doi:10.1002/pbc.26437. PMID 28124468. Unknown parameter |month= ignored (help)
  9. Zuo-Peng Wang, Kai Li, Kui-Ran Dong, Xian-Min Xiao & Shan Zheng (2014). “Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature”. Oncology letters. 8 (5): 2007–2011. doi:10.3892/ol.2014.2489. PMID 25295083. Unknown parameter |month= ignored (help)
  10. Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). “Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases”. Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

The incidence of renal oncocytoma is approximately 3% to 7% of solid renal resected tumors. Patients of all age groups may develop renal oncocytoma. The age of patients can be differ from 10 to 94 years. The incidence of renal oncocytoma increases with age; the median age at the time of surgery is 62 to 68 years. Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.

Epidemiology and Demographics

Incidence

Age

Gender

  • Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.[9]

References

  1. Rosenkrantz, Andrew B.; Hindman, Nicole; Fitzgerald, Erin F.; Niver, Benjamin E.; Melamed, Jonathan; Babb, James S. (2010). “MRI Features of Renal Oncocytoma and Chromophobe Renal Cell Carcinoma”. American Journal of Roentgenology. 195 (6): W421–W427. doi:10.2214/AJR.10.4718. ISSN 0361-803X.
  2. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  3. H. Choi, U. A. Almagro, J. T. McManus, D. H. Norback & S. C. Jacobs (1983). “Renal oncocytoma. A clinicopathologic study”. Cancer. 51 (10): 1887–1896. PMID 6831354. Unknown parameter |month= ignored (help)
  4. M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter |month= ignored (help)
  5. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  6. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  7. M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter |month= ignored (help)
  8. Dechet, Christopher B.; Bostwick, David G.; Blute, Michael L.; Bryant, Sandra C.; Zincke, Horst (1999). “RENAL ONCOCYTOMA: MULTIFOCALITY, BILATERALISM, METACHRONOUS TUMOR DEVELOPMENT AND COEXISTENT RENAL CELL CARCINOMA”. Journal of Urology. 162 (1): 40–42. doi:10.1097/00005392-199907000-00010. ISSN 0022-5347.
  9. Yusenko, Maria V (2010). “Molecular pathology of renal oncocytoma: A review”. International Journal of Urology. 17 (7): 602–612. doi:10.1111/j.1442-2042.2010.02574.x. ISSN 0919-8172.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).

Risk Factors

Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).

References

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

There is insufficient evidence to recommend routine screening for renal oncocytoma.

Screening

There is insufficient evidence to recommend routine screening for renal oncocytoma.

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]

Overview

The median age at the time of surgery is 62 to 68 years. In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen. Prognosis is generally excellent, There are only two cases of metastatic renal oncocytoma were reported. Since the definite diagnosis is maintain just after surgery, most of patients are undergone operation.

Natural History, Complications, and Prognosis

Natural History

  • The median age at the time of surgery is 62 to 68 years. [1]
  • In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen.[2][3]

Prognosis

References

  1. 1.0 1.1 Neuzillet, Yann; Lechevallier, Eric; Andre, March; Daniel, Laurent; Nahon, Olivier; Coulange, Christian (2005). “Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy”. Urology. 66 (6): 1181–1185. doi:10.1016/j.urology.2005.06.001. ISSN 0090-4295.
  2. M. R. Licht, A. C. Novick, R. R. Tubbs, E. A. Klein, H. S. Levin & S. B. Streem (1993). “Renal oncocytoma: clinical and biological correlates”. The Journal of urology. 150 (5 Pt 1): 1380–1383. PMID 8411404. Unknown parameter |month= ignored (help)
  3. Dechet, Christopher B.; Bostwick, David G.; Blute, Michael L.; Bryant, Sandra C.; Zincke, Horst (1999). “RENAL ONCOCYTOMA: MULTIFOCALITY, BILATERALISM, METACHRONOUS TUMOR DEVELOPMENT AND COEXISTENT RENAL CELL CARCINOMA”. Journal of Urology. 162 (1): 40–42. doi:10.1097/00005392-199907000-00010. ISSN 0022-5347.
  4. Lieber MM (1990). “Renal oncocytoma: prognosis and treatment”. European Urology. 18 Suppl 2: 17–21. PMID 2226597.
  5. B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter |month= ignored (help)
  6. Leo Romis, Luca Cindolo, Jean Jacques Patard, Giovanni Messina, Vincenzo Altieri, Laurent Salomon, Claude Clement Abbou, Dominique Chopin, Bernard Lobel & Alexandre de La Taille (2004). “Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database”. European urology. 45 (1): 53–57. PMID 14667516. Unknown parameter |month= ignored (help)
  7. D. B. Spring, R. C. Ulirsch, W. R. Starke & S. Jr Brown (1985). “Renal oncocytoma followed for eighteen years without resection”. Urology. 26 (4): 389–392. PMID 3901483. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Diagnosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH